UK On Cusp Of Value-Based Procurement With NHS Future Operating Model Going Live

The UK's complex system of procuring medical technology for use in the National Health Service is being simplified. A new system will go live on May 8 under the Future Operating Model (FOM), an initiative that prioritizes outcomes-based rationales and allows for gain-sharing, while also targeting annual NHS savings. At this early stage, the device industry and health-care providers are both displaying a mix of optimism and skepticism.

uk pound coins and uk flag

The UK's National Health Service Supply Chain contract ended andproposals from a government reviewto reduce cost variation in NHS England's secondary care setting signaled a need to rethink the complex and costly NHS procurement methods for medical technology. The plan that emerged, the Future Operating Model, is designed to save NHS money annually, but not in the transactional sense. Instead, it deploys value-based health-care concepts that are designed to yield sustainable benefits for patients, as well as the payer and provider. Also see "UK Outlook 2018: Medtech Readies For Change To FOM System Of Value-Based Procurement" - Medtech Insight, 8 February, 2018.

FOM was the focus of an event hosted by the Association of British Healthcare Industries, the UK medtech industry association,...

More from Policy & Regulation

More from Medtech Insight

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

 

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Milner Pitch Day: Multiomic Pathology, Microcancer Avatars And Cell Morphology Intelligence

 

The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

 

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.